Imipramine for treatment of esophageal hypersensitivity and functional heartburn: A randomized placebo-controlled trial

American Journal of Gastroenterology

Volumn 111, Issue 2, 2016, Pages 217-224

  Limsrivilai, Julajak ^a   Charatcharoenwitthaya, Phunchai ^a   Pausawasdi, Nonthalee ^a   Leelakusolvong, Somchai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BLURRED VISION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONSTIPATION; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ESOPHAGEAL PH MONITORING; ESOPHAGUS DISEASE; ESOPHAGUS HYPERSENSITIVITY; EYE PAIN; FATIGUE; FEMALE; HEART PALPITATION; HEARTBURN; HUMAN; HYPERSENSITIVITY; MALE; PATIENT SAFETY; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; URINARY URGENCY; XEROSTOMIA; AGED; COMPLICATION; GASTROESOPHAGEAL REFLUX; HYPERESTHESIA; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DOUBLE-BLIND METHOD; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; HYPERESTHESIA; IMIPRAMINE; MALE; MIDDLE AGED; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84954349892     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2015.413     Document Type: Article

References (25)

1. Modlin IM, Hunt RH, Malfertheiner P, et al. Diagnosis and management of non-erosive reflux disease-the Vevey NERD Consensus Group. Digestion 2009; 80: 74-88
2. Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005; 40: 275-85
3. Mishima I, Adachi K, Arima N, et al. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol 2005; 40: 1005-9
4. Zagari RM, Fuccio L, Wallander MA, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut 2008; 57: 1354-9
5. Dean BB, Gano AD Jr, Knight K, et al. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004; 2 : 656-64
6. Shay SS, Bomeli S, Richter J. Multichannel intraluminal impedance accurately detects fasting, recumbent reflux events and their clearing. Am J Physiol Gastrointest Liver Physiol 2002; 283: G376-83
7. Skopnik H, Silny J, Heiber O, et al. Gastroesophageal reflux in infants: evaluation of a new intraluminal impedance technique. J Pediatr Gastroenterol Nutr 1996; 23: 591-8
8. Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006; 55: 1398-402
9. Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut 2009; 58: 295-309
10. Ford AC, Talley NJ, Schoenfeld PS, et al. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 2009; 58: 367-78
11. Lacy BE, Talley NJ, Locke GR 3rd, et al. Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther 2012; 36: 3-15
12. Peghini PL, Katz PO, Castell DO. Imipramine decreases oesophageal pain perception in human male volunteers. Gut 1998; 42: 807-13
13. Allen CJ, Parameswaran K, Belda J, et al. Reproducibility, validity, and responsiveness of a disease-specifi c symptom questionnaire for gastroesophageal reflux disease. Dis Esophagus 2000; 13: 265-70
14. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual The Health Institute: Boston, MA, USA, 1994
15. Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and defi nitions of acid, non-acid, and gas reflux. Gut 2004; 53: 1024-31
16. Bredenoord AJ, Weusten BL, Smout AJ. Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut 2005; 54: 1810-7
17. Galmiche JP, Clouse RE, Balint A, et al. Functional esophageal disorders. Gastroenterology 2006; 130: 1459-65
18. Knowles CH, Aziz Q. Visceral hypersensitivity in non-erosive reflux disease. Gut 2008; 57: 674-83
19. Broekaert D, Fischler B, Sifrim D, et al. Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a doubleblind, placebo-controlled study. Aliment Pharmacol Ther 2006; 23: 365-70
20. Viazis N, Keyoglou A, Kanellopoulos AK, et al. Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study. Am J Gastroenterol 2012; 107 : 1662-7
21. Ostovaneh MR, Saeidi B, Hajifathalian K, et al. Comparing omeprazole with fl uoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: double-blind placebocontrolled trial. Neurogastroenterol Motil 2014; 26: 670-8
22. Forcelini CM, Tomiozzo JC Jr, Farre R, et al. Effect of nortriptyline on brain responses to painful esophageal acid infusion in patients with non-erosive reflux disease. Neurogastroenterol Motil 2014; 26: 187-95
23. Hershcovici T, Jha Lokesh, Gadam R, et al. Comparison of therapeutic strategies for patients with refractory gastroesophageal reflux disease (GERD)-a randomized, double blind, placebo controlled trial. Gastroenterology 2011; 140: S-579
24. Gorard DA, Libby GW, Farthing MJ. Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome. Aliment Pharmacol Ther 1994; 8: 159-66
25. McColl E, Junghard O, Wiklund I, et al. Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients? Am J Gastroenterol 2005; 100: 11-18